CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Advertisement

Nipro April 2026
Clinical Research v3i3

Business Partnering – The Way Forward for Cryogenics

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-13.pdf
Continue Reading →
Clinical Research v3i3

Determination of Efficacy of AnvirzelTM in 37 Established Cancer Cell Lines

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-12.pdf
Continue Reading →
Drug Discovery, Development & Delivery v3i3

Tox and ecotox – What’s the Point?

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-Volume-3-Issue-3-8.pdf
Continue Reading →
Editorial Archive

Pharmacotherapy in older adults

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web.pdf
Continue Reading →
Editorial Archive

Phage in therapy and Prophylaxis ?History and Future Prospects

https://international-pharma.com/wp-content/uploads/2012/04/Pages-from-IPI-V3I3-web-5.pdf
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026